150 related articles for article (PubMed ID: 36192532)
1. Patient-friendly extemporaneous formulation of bisoprolol: application to stability and bioavailability studies.
El-Masry SM; Helmy SA; Helmy SAM; Mazyed EA
Drug Deliv Transl Res; 2023 Mar; 13(3):795-810. PubMed ID: 36192532
[TBL] [Abstract][Full Text] [Related]
2. Stability of an alternative extemporaneous captopril fast-dispersing tablet formulation versus an extemporaneous oral liquid formulation.
Pabari RM; McDermott C; Barlow J; Ramtoola Z
Clin Ther; 2012 Nov; 34(11):2221-9. PubMed ID: 23149007
[TBL] [Abstract][Full Text] [Related]
3. Formulation and Stability Study of Eslicarbazepine Acetate Oral Suspensions for Extemporaneous Compounding.
Zhao F; Dave VS; Mar MZ; Perri JR
Int J Pharm Compd; 2018; 22(5):433-439. PubMed ID: 30384342
[TBL] [Abstract][Full Text] [Related]
4. Extemporaneous benznidazole oral suspension prepared from commercially available tablets for treatment of Chagas disease in paediatric patients.
García MC; Manzo RH; Jimenez-Kairuz AF
Trop Med Int Health; 2015 Jul; 20(7):864-70. PubMed ID: 25784402
[TBL] [Abstract][Full Text] [Related]
5. Extemporaneous compounding of oral liquid dosage formulations and alternative drug delivery methods for anticancer drugs.
Lam MS
Pharmacotherapy; 2011 Feb; 31(2):164-92. PubMed ID: 21275495
[TBL] [Abstract][Full Text] [Related]
6. Formulation and stability of diazepam suspension compounded from tablets.
Strom JG; Kalu AU
Am J Hosp Pharm; 1986 Jun; 43(6):1489-91. PubMed ID: 3728485
[TBL] [Abstract][Full Text] [Related]
7. Compounding and stability evaluation of atorvastatin extemporaneous oral suspension using tablets or pure powder.
Zaid AN; Assali M; Zalmout S; Basheer A
Eur J Hosp Pharm; 2017 May; 24(3):157-161. PubMed ID: 31156928
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of an extemporaneous suspension of propafenone made from tablets.
Olguín HJ; Pérez CF; Pérez JF; Mendiola BR; Portugal MC; Chávez JB
Biopharm Drug Dispos; 2006 Jul; 27(5):241-5. PubMed ID: 16586461
[TBL] [Abstract][Full Text] [Related]
9. Bioavailability of two oral suspension and two oral tablet formulations of acyclovir 400 mg: two single-dose, open-label, randomized, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Absalón-Reyes JA; Novoa-Heckel G; de Lago A; Oliva I; Rodríguez Z; González-de la Parra M; Burke-Fraga V; Namur S
Clin Ther; 2007 Jun; 29(6):1146-52. PubMed ID: 17692728
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.
Palma-Aguirre JA; Villalpando-Hernández J; Novoa-Heckel G; Oliva I; Cariño L; López-Bojórquez E; Burke-Fraga V; Namur S; González-de la Parra M
Clin Ther; 2009 Feb; 31(2):399-410. PubMed ID: 19302912
[TBL] [Abstract][Full Text] [Related]
11. Palatability and relative bioavailability of an extemporaneous carbamazepine oral suspension.
Bloomer D; Dupuis LL; MacGregor D; Soldin SJ
Clin Pharm; 1987 Aug; 6(8):646-9. PubMed ID: 3691011
[TBL] [Abstract][Full Text] [Related]
12. The stability of quetiapine oral suspension compounded from commercially available tablets.
Tran J; Gervase MA; Evans J; Deville R; Dong X
PLoS One; 2021; 16(8):e0255963. PubMed ID: 34375349
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Physical, Chemical and Microbiological Stability of Losartan Potassium 5 mg/mL Extemporaneous Oral Liquid Suspension.
Foley L; Toney J; Barlow JW; O'Connor M; Fitzgerald-Hughes D; Ramtoola Z
Molecules; 2021 Jan; 26(2):. PubMed ID: 33435555
[TBL] [Abstract][Full Text] [Related]
14. Preparation and stability evaluation of extemporaneous oral suspension of valsartan using commercially available tablets.
Zaid AN; Assali M; Qaddomi A; Ghanem M; Zaaror YA
Int J Pharm Compd; 2014; 18(2):169-74. PubMed ID: 24881122
[TBL] [Abstract][Full Text] [Related]
15. Stability of an extemporaneous alcohol-free melatonin suspension.
Johnson CE; Cober MP; Thome T; Rouse E
Am J Health Syst Pharm; 2011 Mar; 68(5):420-3. PubMed ID: 21330684
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical and Microbiological Stability of Compounded Metronidazole Suspensions in PCCA SuspendIt.
Pramar YV; Mandal TK; Bostanian LA; Le G; Morris TC; Graves RA
Int J Pharm Compd; 2021; 25(2):169-175. PubMed ID: 33798117
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence study of 2.5 mg film-coated bisoprolol tablets in healthy volunteers.
Buś-Kwaśnik K; Rudzki PJ; Ksycińska H; Leś A; Serafin-Byczak K; Raszek J; Bielak A; Wybraniec A; Płatek AE; Szymański FM; Łazowski T
Kardiol Pol; 2017; 75(1):48-54. PubMed ID: 27391910
[TBL] [Abstract][Full Text] [Related]
18. A new esomeprazole packet (sachet) formulation for suspension: in vitro characteristics and comparative pharmacokinetics versus intact capsules/tablets in healthy volunteers.
Bladh N; Blychert E; Johansson K; Backlund A; Lundin C; Niazi M; Pettersson G; Fjellman M
Clin Ther; 2007 Apr; 29(4):640-9. PubMed ID: 17617287
[TBL] [Abstract][Full Text] [Related]
19. Physicochemical and Microbiological Stability of Amitriptyline Hydrochloride Oral Liquid Dosage Forms in PCCA Base, SuspendIt.
Pramar YV; Mandal TK; Bostanian LA; Kader C; Morris TC; Graves RA
Int J Pharm Compd; 2022; 26(4):342-351. PubMed ID: 35820140
[TBL] [Abstract][Full Text] [Related]
20. Extemporaneous Compounding and Physiological Modeling of Amlodipine/Valsartan Suspension.
Aabed WJ; Radwan AH; Zaid AN; Shraim NY
Int J Hypertens; 2021; 2021():6695744. PubMed ID: 33824764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
